FLUTEX

This brand name is authorized in Nigeria.

Active ingredients

The drug FLUTEX contains one active pharmaceutical ingredient (API):

1	Fluoxetine UNII I9W7N6B1KJ - FLUOXETINE HYDROCHLORIDE
	Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as α1, α2, and β-adrenergic; serotonergic; dopaminergic; histaminergic1; muscarinic; and GABA receptors.
	Read more about Fluoxetine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-8881	Capsule	Flutex 20 mg Capsules CAP 20 mg 3 x 10's (in Alu-Alu blisters)	Fluoxetine Capsules USP 20 mg. White/White coloured hard gelatin 'size 2' capsules having printed 'FLUTEX' in green colour on caps and printed 'FIDSON' in green colour on body, containing white powder in each capsule. Each hard gelatin capsule contains: Fluoxetine Hydrochloride USP equiv. to Fluoxetine 20 mg, Excipients q.s. Approved colours are used in hard gelatin capsule shell. Excipients: Lactose 90.026 mg, Lactose DC 40.40 mg, Maize starch 97.10 mg, Purified Talcum 2.50 mg, Colloidal Silicon Dioxide 5.2 mg, Magnesium stearate 1.330 mg	06/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AB03	Fluoxetine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AB Selective serotonin reuptake inhibitors
Discover more medicines within N06AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-8881